---

November 06, 2023

Predictmedix AI Unveils Safe Entry Stations to Delegates from 30 Nations at D-30 Event in New Delhi

Toronto, Ontario – November 6, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud…

Read full release →

November 02, 2023

Predictmedix AI Showcases Innovative Impairment Screening Technology at a 30-Country Summit in India, Focusing on Combating Drug Addiction Globally

Toronto, Ontario – November 2, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud…

Read full release →

October 27, 2023

Predictmedix AI Accelerates Corporate Expansion During Month-Long International Campaign

Toronto, Ontario – October 27, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), has just returned from a fruitful month of international endeavors, during which the company achieved significant…

Read full release →

September 20, 2023

Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India

Toronto, Ontario – September 20, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today announced that visas have been granted for a strategic visit to India. The primary purpose of…

Read full release →

September 12, 2023

Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues

Toronto, Ontario – September 12, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is proud to announce its recent feature in the prestigious Toronto Star newspaper, accompanied by a compelling…

Read full release →